
SNAP-8 (10 mg Vial)
SNAP-8 (Acetyl Octapeptide-3) is a synthetic octapeptide originally developed as a cosmeceutical ingredient for anti-wrinkle effects. It is an extended analog of the hexapeptide Argireline, designed to mimic part of the SNAP-25 protein involved in neuromuscular signaling. By competitively inhibiting SNAP-25 in the SNARE complex, SNAP-8 attenuates acetylcholine release at neuromuscular junctions, thereby relaxing facial muscle contractions without causing paralysis. This educational protocol presents a once-daily subcutaneous approach using a practical dilution for clear insulin-syringe measurements.
Detailed protocol below.
| Week | Daily Dose (mcg) | Units (per injection) (mL) |
|---|---|---|
| Weeks 1–4 | 330 mcg (0.33 mg) | 10 units (0.10 mL) |
| Weeks 5–8 | 500 mcg (0.50 mg) | 15 units (0.15 mL) |
| Weeks 9–12 | 1,000 mcg (1.0 mg) | 30 units (0.30 mL) |
| Weeks 13–16 (Optional) | 1,000 mcg (1.0 mg) | 30 units (0.30 mL) |
- •Peptide Vials (SNAP-8, 10 mg each):
- •Insulin Syringes (U-100):
- •Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.
- •Alcohol Swabs: One for the vial stopper + one for the injection site each day.
International Journal of Cosmetic Science
Argireline hexapeptide with antiwrinkle activity (human study; 10% cream reduced wrinkle depth ~30% after 30 days)
View sourceJournal of Analytical Science and Technology
Method development for acetyl octapeptide-3 (SNAP-8) analysis by LC-MS/MS; stability and analytical characterization
View sourceJournal of Drugs in Dermatology
Open-label 14-week trial of multi-peptide serum (including SNAP-8); statistically significant smoothing of expression lines with good tolerability
View sourceAnnals of Dermatology
Clinical safety and efficacy evaluation of dissolving microneedle patch containing SNAP-8; 24-subject trial showed significant wrinkle reduction and improved elasticity over 4 weeks with no adverse effects
View sourceFrontiers in Chemistry
Cosmeceutical peptides review; SNAP-8 mechanism (SNARE complex inhibition), ~30% greater activity than Argireline, and enhanced stability
View sourceAdvances in Therapy
Subcutaneous injection of drugs: literature review of factors influencing pain sensation; fine gauge needles and small volumes minimize discomfort
View sourceMedlinePlus (NLM/NIH)
Subcutaneous injection patient instructions; technique, site selection, and rotation guidance
View sourceGenScript Technical Resources
Peptide storage and handling guidelines; lyophilized storage at −20 °C, reconstituted refrigeration, and stability considerations
View sourceCDC
Vaccine administration: subcutaneous route guidance (angle, site, and technique)
View sourceCDC (Subcut Injection PDF)
Technique diagram and site guidance for subcutaneous injections
View sourceNCBI Bookshelf
Best practices for injection technique (asepsis, preparation, administration, and site rotation)
View source
Educational content adapted from peptidedosages.com. Not medical advice.